miR-129-5p Promotes Osteogenic Differentiation of BMSCs and Bone Regeneration via Repressing Dkk3

Changming Zhao1,2, Yulin Gu1,3, Yan Wang4

  • 1Medical School of Chinese PLA, Beijing 100853, China.

Abstract

Insights

MicroRNA-129-5p enhances bone marrow mesenchymal stem cell differentiation and bone regeneration. Targeting the miR-129-5p/Dkk3 pathway shows promise for treating bone defects and bone loss.

Area of Science:

  • Stem Cell Biology
  • Molecular Biology
  • Regenerative Medicine

Background:

  • MicroRNAs (miRNAs) are critical regulators of osteogenic differentiation.
  • The precise mechanisms underlying miRNA involvement in bone formation are not fully understood.

Purpose of the Study:

  • To investigate the role of miR-129-5p in regulating bone marrow mesenchymal stem cell (BMSC) differentiation.
  • To explore the impact of miR-129-5p on bone regeneration in vivo and in vitro.

Main Methods:

  • Lentiviral transduction of BMSCs with miR-129-5p mimic or inhibitor.
  • Assessment of osteogenic differentiation using alkaline phosphatase and alizarin red staining.
  • Quantitative RT-PCR and western blot for osteogenic gene expression.
  • In vivo mouse calvarial defect model with Micro-CT and histological analysis.
  • Luciferase reporter assays to identify Dkk3 as a direct target of miR-129-5p.

Main Results:

  • miR-129-5p expression increased under osteogenic conditions.
  • Overexpression of miR-129-5p significantly promoted BMSC osteogenic differentiation in vitro.
  • BMSCs with miR-129-5p mimic showed enhanced bone regeneration in vivo.
  • miR-129-5p directly targets Dickkopf3 (Dkk3), inhibiting its expression.
  • Dkk3 was found to interact with β-catenin.

Conclusions:

  • miR-129-5p promotes BMSC osteogenic differentiation and bone regeneration.
  • The miR-129-5p/Dkk3 axis represents a potential therapeutic target for bone defects and bone loss.